AOD-9604 (5 mg & 10 mg)

Research Peptide for Fat Metabolism & Body Composition

AOD-9604 peptide is a fragment of human growth hormone (HGH 176-191) that has been widely studied for its potential effects on fat metabolism, energy balance, and body-composition regulation. Unlike full-length HGH, this sequence acts selectively on lipid breakdown without stimulating insulin-like growth factor 1 (IGF-1). Because of that targeted mechanism, AOD-9604 has become a key compound for researchers investigating metabolic pathways related to fat loss and energy utilization.

At GRAM Peptides, AOD-9604 peptide is pharmacist-formulated and verified by independent third-party testing for purity and potency. All material is supplied strictly for Research Use Only (RUO).

Understanding AOD-9604

AOD-9604 stands for “Anti-Obesity Drug 9604,” a modified fragment corresponding to amino acids 176 through 191 of the growth-hormone molecule. Laboratory research suggests this region retains the lipolytic (fat-burning) properties of HGH while eliminating unwanted anabolic effects.

In preclinical models, this compound has been observed to:

• Increase fat oxidation and lipolysis in adipose tissue
• Reduce lipogenesis (the conversion of carbohydrates into fat)
• Improve fat mobilization during caloric restriction and exercise
• Support metabolic efficiency without altering glucose levels

This selective action makes AOD-9604 a useful tool in studies of metabolic health and obesity pathophysiology.

Benefits Observed in Research

Research on AOD-9604 peptide indicates several potential applications across metabolic science:

• Enhanced Fat Metabolism – May increase lipolytic activity and energy release from stored fat.
• Weight Management – Examined for reducing body fat mass without impacting lean tissue.
• Improved Energy Utilization – Supports metabolic efficiency through fatty-acid oxidation.
• Joint and Cartilage Support – Some studies suggest tissue-repair potential via anti-inflammatory mechanisms.
• Stable Glucose Levels – Does not stimulate insulin or affect blood sugar in preclinical models.

These findings highlight AOD-9604 as a distinct research tool separate from anabolic growth hormone compounds.

The Science Behind AOD-9604

The AOD-9604 peptide sequence (176-191) appears to interact with β-adrenergic receptors in adipose tissue, initiating fat breakdown similar to that triggered by growth hormone. However, because it lacks the regions responsible for cell proliferation, it does not induce muscle growth or alter IGF-1 levels.

In experimental settings, AOD-9604 has been linked to:

• Increased fatty-acid mobilization and oxidation
• Enhanced thermogenic activity in adipocytes
• Improved mitochondrial efficiency and energy output
• Potential protective effects on cartilage tissue

These mechanisms make AOD-9604 valuable for exploring obesity, metabolic syndrome, and joint health.

For scientific references, see PubMed Research on AOD-9604.

Why Choose GRAM Peptides

• Pharmacist-Formulated – Developed by a licensed compounding pharmacist with over 20 years of experience.
• USA-Made – Produced in controlled, ISO-compliant laboratories.
• Third-Party Tested – Verified for identity, purity, and potency.
• Transparent Documentation – Certificates of Analysis available upon request.

Researchers choose GRAM Peptides for consistent quality and professional support in every batch of AOD-9604 peptide.

Research Applications

AOD-9604 peptide is being investigated in several key fields:

• Obesity Research – Mechanistic studies of fat oxidation and storage.
• Metabolic Health – Models examining lipid profiles and insulin response.
• Sports Science – Exploration of energy balance and recovery without muscle hypertrophy.
• Cartilage Repair – Investigated for potential support in joint and connective tissue models.
• Combination Therapy Studies – Evaluated alongside Tirzepatide and L-Carnitine to analyze metabolic synergy.

These research avenues continue to expand as interest in non-anabolic metabolic peptides grows.

Frequently Asked Questions About AOD-9604

What is AOD-9604 peptide?
A growth-hormone fragment (176-191) studied for its selective effects on fat metabolism and energy balance.

Is AOD-9604 FDA-approved?
No. It is for Research Use Only (RUO) and not for human or veterinary administration.

What dosages are available?
GRAM Peptides offers AOD-9604 in both 5 mg and 10 mg lyophilized vials for laboratory research.

Can AOD-9604 be used with other peptides?
Yes. It is often studied alongside Tirzepatide or Semaglutide to evaluate combined effects on metabolism and fat oxidation.

Does AOD-9604 affect IGF-1 or muscle growth?
No. Its activity is isolated to lipid metabolism without stimulating anabolic pathways.

Related Peptides for Metabolic Research

• Tirzepatide Peptide – Dual GIP/GLP-1 agonist studied for glucose and fat control.
• Semaglutide Peptide – Investigated for appetite and weight management.
• L-Carnitine – Explored for mitochondrial energy and fat transport.

Disclaimer

AOD-9604 peptide is sold strictly for Research Use Only (RUO). Not for human consumption, medical, or veterinary use.